Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete


You May Also Like

Cellectar Biosciences to Present at 29th Annual Roth Conference

MADISON, Wis., March 06, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, ...

TESARO Announces Closing of $155 Million Private Placement

WALTHAM, Mass., March 18, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical ...